A detailed history of Gould Capital, LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Gould Capital, LLC holds 110 shares of JNJ stock, worth $16,997. This represents 0.01% of its overall portfolio holdings.

Number of Shares
110
Previous 110 -0.0%
Holding current value
$16,997
Previous $16,000 6.25%
% of portfolio
0.01%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023

SELL
$160.2 - $179.79 $1,762 - $1,977
-11 Reduced 9.09%
110 $19,000
Q1 2022

Jul 21, 2022

SELL
$158.14 - $179.59 $43,330 - $49,207
-274 Reduced 69.37%
121 $21,000
Q4 2021

Feb 14, 2022

BUY
$155.93 - $173.01 $61,592 - $68,338
395 New
395 $68,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Gould Capital, LLC Portfolio

Follow Gould Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gould Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gould Capital, LLC with notifications on news.